搜索临床试验以:抗病毒治疗(拉米夫定或恩替卡韦)
总计1477个结果
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI)主动,不招人
-
Therapeutic Concepts完全的
-
NovartisNovartis Pharmaceuticals完全的
-
NHS TaysideUniversity of Dundee完全的
-
Merck Sharp & Dohme LLC完全的HIV-1 感染美国, 智利, 法国, 英国
-
SFJ Pharmaceuticals, Inc.SFJ Pharmaceuticals, Inc.终止
-
University of CalgaryCanadian Institutes of Health Research (CIHR)招聘中
-
University of the Basque Country (UPV/EHU)Bioaraba招聘中
-
Societa' Italiana Di Malattie Infettive E Tropicali招聘中
-
MelanomaPRO, Russia招聘中黑色素瘤 | 黑色素瘤(皮肤) | 黑色素瘤 IV 期 | 黑色素瘤 III 期 | 黑色素瘤,II期 | 黑色素瘤,葡萄膜 | 原位黑色素瘤 | 黑色素瘤,眼俄罗斯联邦
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...European Institute of Oncology; ASST Santi Paolo e Carlo招聘中
-
Asan Medical Center完全的
-
ANRS, Emerging Infectious Diseases尚未招聘
-
Pedro CahnViiV Healthcare撤销
-
Uijeongbu St. Mary Hospital未知Proportion of Patients With a Sustained Virological Response (Serum HBV DNA <20 IU/mL) at Week 48
-
GlaxoSmithKline完全的
-
Agouron Pharmaceuticals暂停艾滋病毒感染美国, 加拿大, 波多黎各, 多明尼加共和国
-
Glaxo Wellcome完全的
-
Sun Yat-sen University招聘中
-
National Taiwan University HospitalNational Science Council, Taiwan未知
-
Saint Michael's Medical CenterViiV Healthcare主动,不招人
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)完全的
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)招聘中
-
ViiV HealthcareGlaxoSmithKline; Shionogi完全的感染,人类免疫缺陷病毒 I美国, 西班牙, 德国, 澳大利亚, 加拿大, 比利时, 丹麦, 荷兰, 英国, 法国, 意大利, 罗马尼亚
-
Rigshospitalet, DenmarkUniversity of Copenhagen完全的
-
Hellenic Institute for the Study of Sepsis完全的
-
Peking Union Medical CollegeMinistry of Science and Technology of the People´s Republic of China未知
-
Centers for Disease Control and Prevention未知
-
Duke UniversityGlaxoSmithKline; Kilimanjaro Christian Medical Centre, Tanzania; Kibongoto National Tuberculosis...完全的
-
Newcastle-upon-Tyne Hospitals NHS TrustCancer Research UK完全的